Building Scalable Data Platforms for Spatial Biology with Kenny Workman of LatchBio

Data in Biotech

In this episode of Data in Biotech, Ross Katz sits down with Kenny Workman, co-founder and CTO of LatchBio, to unpack how biotech’s data infrastructure must evolve to meet the demands of next-gen assays. From scalable workflows to high-performance visualization tools, Kenny breaks down the shift from traditional biotech to a future defined by data-driven research and agile cloud platforms.

​​What You'll Learn in This Episode:

• Why spatial biology and high-throughput assays require new data infrastructure strategies
• How LatchBio’s five core components streamline molecular data processing
• The challenges of selling into biotech vs. solution providers and the strategic pivot LatchBio made to address this
• How large language models are revolutionizing public data curation for biotechs
• Why scientific innovation demands better tech adoption across the industry

Meet Our Guest

Kenny Workman is co-founder and CTO of LatchBio, a company transforming biological data infrastructure. A UC Berkeley alum, Kenny brings deep expertise in bioengineering, machine learning, and cloud systems. He was named to Forbes' 2023 "30 Under 30" list for his contributions to computational biology.

About The Host

Ross Katz is Principal and Data Science Lead at CorrDyn. Ross specializes in building intelligent data systems that empower biotech and healthcare organizations to extract insights and drive innovation.

Connect with Our Guest:

• Sponsor: CorrDyn, a data consultancy
• Find out more about Latch Bio
• Connect with Kenny Workman on LinkedIn

Connect with Us:

• Follow the podcast for more insightful discussions on the latest in biotech and data science.
• Subscribe and leave a review if you enjoyed this episode!
• Connect with Ross Katz on LinkedIn

Sponsored by…

This episode is brought to you by CorrDyn, the leader in data-driven solutions for biotech and healthcare. Discover how CorrDyn is helping organizations turn data into breakthroughs at CorrDyn.